Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-19

FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for phentermine and topiramate by Prasco Laboratories, supporting additional regulatory authorization for this obesity w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine and topiramate (Phentermine and topiramate)

Snippet

SUPPL AP for PHENTERMINE AND TOPIRAMATE (PHENTERMINE AND TOPIRAMATE)